JPMA Code of Practice
JPMA member companies must always ensure a high level of ethics and transparency in their business activities, fulfill their accountability regarding interactions with researchers, medical professionals, patient groups, etc., and respond to the trust of society.
The JPMA Code of Practice is a further development of the "Code of Ethical Drug Promotion" and sets forth standards of conduct for all officers and employees of member companies and their interactions with researchers, medical professionals, patient groups, etc. It was developed in January 2013 and was published in May 2017, November 2018, and It was developed in January 2013 and revised in May 2017, November 2018, September 2019, and May 2025.